An unknown Canadian institutional accredited investor agreed to acquire 2.14% stake in Emerald Health Therapeutics, Inc. (TSXV:EMH) from Emerald Health Sciences Inc. for CAD 10 million on January 3, 2018. The buyer is acquiring 2 million shares of Emerald Health Therapeutics at CAD 5 per share. The transaction is certain conditions including, but not limited to, the buyer being satisfied with the results of its due diligence, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities. The transaction is expected to close on or about January 10, 2018.